---

Brought to you by RivalSense - an AI tool for monitoring any company.

RivalSense tracks the most important product launches, fundraising news, partnerships, hiring activities, pricing changes, tech news, vendors, corporate filings, media mentions, and other developments of companies you're following 💡

---

Abridge

🌎 abridge.com

Abridge is a healthcare technology company founded in 2018 that specializes in transforming patient-clinician conversations into structured clinical notes using generative AI. Their platform enhances clinical documentation efficiency, allowing clinicians to focus on patient care while ensuring accurate and auditable AI-generated summaries. Abridge integrates deeply with electronic medical records (EMR) systems, setting industry standards for the responsible use of AI in healthcare.

---

Abridge - Latest News and Updates

• Abridge's generative AI platform was rigorously evaluated by @aboutKP before being deployed across their enterprise.
• Abridge announced new peer-reviewed AI research from Kaiser Permanente in NEJM AI on April 2, 2025.
• Abridge is planning pilots or implementations of ambient speech AI tools in ambulatory and emergency care settings.
• Abridge is evaluating Google's Multi-Cluster Orchestrator to automate workload placement and scaling, aiming to enhance their AI-driven processes, according to Trey Caliva, Staff Platform Engineer.
• Shiv Rao, CEO of Abridge, emphasized the importance of using AI to save time, money, and lives while addressing risks like bias at the American College of Cardiology 2025 Annual Scientific Session.

• Abridge, initially criticized as a 'wrapper' for existing AI models, is now gaining recognition as AI models become commoditized.

---

Sign up to receive regular updates

If you liked the insights, consider following your own companies of interest. Receive weekly insights directly to your inbox using RivalSense.